Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05491980 · ClinicalTrials.gov registry record
Florida Cerebrovascular Disease Biorepository and Genomics Center
A clinical trial of Ischemic Stroke and Intracerebral Hemorrhage, sponsored by Mayo Clinic.
- Active
- Registry status
- 72
- Enrollment target
- 1
- Study location
NCT05491980: Active study of Ischemic Stroke and Intracerebral Hemorrhage, sponsored by Mayo Clinic.
NCT05491980 is a study of Ischemic Stroke and Intracerebral Hemorrhage that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 72 participants, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05491980, a study of Ischemic Stroke and Intracerebral Hemorrhage, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to create a state-wide biorepository and resource center for cerebrovascular diseases in Florida, which will include collecting medical history information and blood from subjects affected by cerebrovascular disease. The information and blood samples collected may be used in future research for the study of cerebrovascular disease and to learn about, prevent or treat other health problems.
Primary Outcome
Number of participants to experience new diagnosis of TIA or stroke.
Conditions Studied
Study Locations (1)
Florida
- Mayo Clinic Florida - Jacksonville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2022-08-02 |
| Est. Completion | 2026-04 |
What the registry record for NCT05491980 still lists
NCT05491980 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (95% lower).
The record links to 10 conditions, with Ischemic Stroke appearing as the primary indexed condition, and to 0 interventions.
NCT05491980 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05491980 about?
NCT05491980 is a clinical study titled "Florida Cerebrovascular Disease Biorepository and Genomics Center". The purpose of this study is to create a state-wide biorepository and resource center for cerebrovascular diseases in Florida, which will include collecting medical history information and blood from subjects affected by cerebrovascular disease. The information and blood samples collected may be use...
What is the current status of trial NCT05491980?
This trial is currently active not recruiting. The enrollment target is 72 participants. The study started on 2022-08-02. Estimated completion is 2026-04.
What conditions does trial NCT05491980 study?
This clinical trial studies the following conditions: Ischemic Stroke, Intracerebral Hemorrhage, Vascular Dementia, Cerebrovascular Disease, Transient Ischemic Attack.
Who is sponsoring clinical trial NCT05491980?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05491980 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05491980's enrollment target sits among peer trials
72 36th of 66 higher than 30 of 66 other Ischemic Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ischemic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study Of Vagus Nerve Stimulation (VNS) With Mobility Training For Gait Recovery After Chronic Ischemic Stroke
RECRUITING · NA
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
-
Transitions of Care for Stroke Patients
RECRUITING
-
Personalized Transcranial Direct Current Stimulation in Stroke Recovery
RECRUITING · NA
-
Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe
RECRUITING · NA
-
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI